RecruitingPhase 3NCT07654374A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsGulfport, MS · Ridgeland, MS · +72 more sites
RecruitingPhase 3NCT07667803A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMSponsor: AstraZenecaRidgeland, MS · +55 more sites
RecruitingPhase 2NCT07340320A Study of CX11 Tablets in Patients With Type 2 Diabetes MellitusSponsor: Corxel PharmaceuticalsRidgeland, MS · +33 more sites
RecruitingPhase 3NCT07662109A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes MellitusSponsor: AstraZenecaRidgeland, MS · +39 more sites